Accessibility Menu
Alcon Stock Quote

Alcon (NYSE: ALC)

$76.65
(0.3%)
+0.24
Price as of October 23, 2025, 2:56 p.m. ET

KEY DATA POINTS

Current Price
$76.65
Daily Change
(0.3%) +$0.24
Day's Range
$76.12 - $76.9
Previous Close
$76.4
Open
$76.27
Beta
0.84
Volume
807,511
Average Volume
2,188,637
Market Cap
37.8B
Market Cap / Employee
$76.40M
52wk Range
$71.55 - $99.2
Revenue
-
Gross Margin
0.55%
Dividend Yield
0.44%
EPS
$2.15
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Alcon Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
ALC-18.98%+24.33%+4.45%+33%
S&P+14.5%+93.32%+14.09%+133%

Alcon Company Info

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$2.60B4.0%
Gross Profit$1.39B1.0%
Gross Margin53.47%-1.6%
Market Cap$43.66B-0.6%
Market Cap / Employee$1.71M0.0%
Employees25.6K1.1%
Net Income$176.00M-21.1%
EBITDA$602.00M-5.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$1.41B2.6%
Accounts Receivable$1.99B8.9%
Inventory2.4K2.7%

Liabilities

Q2 2025YOY Change
Long Term Debt$5.10B4.5%
Short Term Debt$157.00M-24.5%

Ratios

Q2 2025YOY Change
Return On Assets3.51%-0.2%
Return On Invested Capital1.66%1.3%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$403.00M-8.0%
Operating Free Cash Flow$505.00M-4.7%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings42.5241.1941.5540.671.72%
Price to Book2.361.962.181.99-5.95%
Price to Sales5.104.264.724.38-4.87%
Price to Tangible Book Value15.2011.2511.6812.71-14.05%
Price to Free Cash Flow TTM38.1528.6630.7630.24-26.52%
Enterprise Value to EBITDA82.4165.5564.0379.374.97%
Free Cash Flow Yield2.6%3.5%3.3%3.3%36.10%
Return on Equity5.6%4.8%5.2%5.0%-7.55%
Total Debt$5.12B$5.14B$5.20B$5.26B3.36%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.